|
WDR35 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 9.714200E-01 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
6.436800E-01 |
| Normal-vs-Stage2 |
6.346000E-01 |
| Normal-vs-Stage3 |
5.015400E-01 |
| Normal-vs-Stage4 |
8.213200E-01 |
| Stage1-vs-Stage2 |
4.672000E-01 |
| Stage1-vs-Stage3 |
7.523600E-01 |
| Stage1-vs-Stage4 |
9.894600E-01 |
| Stage2-vs-Stage3 |
3.842600E-01 |
| Stage2-vs-Stage4 |
6.342800E-01 |
| Stage3-vs-Stage4 |
8.394600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
8.380400E-01 |
| Normal-vs-AfricanAmerican |
6.481000E-01 |
| Normal-vs-Asian |
3.991200E-01 |
| Caucasian-vs-AfricanAmerican |
5.423800E-01 |
| Caucasian-vs-Asian |
5.035400E-01 |
| AfricanAmerican-vs-Asian |
3.670400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.919600E-01 |
| Normal-vs-Female |
6.403900E-02 |
| Male-vs-Female |
9.061400E-03 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
3.271200E-01 |
| Normal-vs-Extreme_Weight |
9.604000E-02 |
| Normal-vs-Obese |
2.441600E-01 |
| Normal-vs-Extreme_Obese |
4.131600E-01 |
| Normal_Weight-vs-Extreme_Weight |
6.513800E-01 |
| Normal_Weight-vs-Obese |
8.017700E-02 |
| Normal_Weight-vs-Extreme_Obese |
7.146000E-01 |
| Extreme_Weight-vs-Obese |
1.619660E-02 |
| Extreme_Weight-vs-Extreme_Obese |
9.275600E-01 |
| Obese-vs-Extreme_Obese |
1.917450E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
4.864100E-02 |
| Normal-vs-Age(41-60Yrs) |
1.948420E-01 |
| Normal-vs-Age(61-80Yrs) |
1.469760E-01 |
| Normal-vs-Age(81-100Yrs) |
1.293440E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.602000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
7.759700E-03 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.004270E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
8.356100E-03 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.042430E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
5.116800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
2.186000E-01 |
| Normal-VS-Type2 PRCC |
1.856500E-03 |
| Normal-VS-KIRP CIMP |
4.649800E-01 |
| Normal-VS-Unclassified PRCC |
2.669200E-01 |
| Type1 PRCC-VS-Type2 PRCC |
4.39720000000587E-05 |
| Type1 PRCC-VS-KIRP CIMP |
5.957800E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
5.488400E-01 |
| Type2 PRCC-VS-KIRP CIMP |
1.111580E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
6.419300E-03 |
| KIRP CIMP-VS-Unclassified PRCC |
9.022000E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
9.062600E-03 |
| Normal-vs-N1 |
3.805000E-01 |
| Normal-vs-N2 |
2.519000E-01 |
| N0-vs-N1 |
3.014000E-02 |
| N0-vs-N2 |
8.722800E-01 |
| N1-vs-N2 |
3.855000E-01 |
|
|
